Branded Legacy, Inc. To Add $320,000 In Revenue With New White Label Contract
Branded Legacy, Inc. To Add $320,000 In Revenue With New White Label Contract
Royal Biotek Enhances Everglade Line with New Products
Royal Biotek 推出新產品增強了 Everglade 產品線
MELBOURNE, Fla., April 9, 2024 /PRNewswire/ -- Royal Biotek, a subsidiary of Branded Legacy, Inc. (Symbol: $BLEG), is proud to announce the expansion of its Everglade line, a distinguished collection of cannabis products, crafted exclusively for Surge Distribution Co. This expansion not only builds on the initial success of the Everglade gummies but also marks a significant stride in Royal Biotek's commitment to delivering tailored cannabis solutions that meet the specific needs of Surge Distribution's diverse clientele.
佛羅里達州墨爾本，2024年4月9日 /PRNewswire/ — Branded Legacy, Inc.（代碼：$BLEG）的子公司Royal Biotek自豪地宣佈擴大其Everglade系列，這是專爲Surge Distribution Co.精心設計的傑出大麻產品系列。此次擴張不僅建立在Everglade軟糖初步成功的基礎上，而且還標誌着Royal Biotek在提供量身定製的大麻解決方案以滿足Surge Distribution多元化客戶群的特定需求方面取得了長足的進步。
David Oswald, CEO of Royal Biotek, expressed enthusiasm about the launch: "We are thrilled to expand the Everglade line for Surge Distribution with the introduction of THCA Flower, featuring the iconic imagery and branding that have contributed to the success of this line. This addition is a testament to our ongoing commitment to customer satisfaction and reinforces our position as a trusted leader in premium cannabis offerings."
Royal Biotek首席執行官大衛·奧斯瓦爾德對本次發佈表示了熱情：“我們很高興通過推出THCA Flower來擴展Surge Distribution的Everglade產品線，其中的標誌性圖像和品牌爲該系列的成功做出了貢獻。這一新增證明了我們對客戶滿意度的持續承諾，並鞏固了我們作爲優質大麻產品領域值得信賴的領導者的地位。”
Under this enhanced partnership, Royal Biotek will provide Surge Distribution with 4,000 packages of THCA Flower twice each quarter, generating a consistent revenue stream with each order valued at approximately $40,000. This development is expected to significantly contribute to Branded Legacy's revenue growth in the early stages of the second quarter.
根據這種加強的合作伙伴關係，Royal Biotek將每季度兩次向Surge Distribution提供4,000包四氫大麻酚鮮花，每份訂單的價值約爲40,000美元，從而產生穩定的收入來源。預計這一發展將在第二季度初爲Branded Legacy的收入增長做出重大貢獻。
The expansion reflects Royal Biotek's unwavering commitment to excellence, quality, and integrity within the cannabis industry. Every product within the Surge Everglade line is meticulously crafted using only the finest ingredients and cutting-edge manufacturing techniques to ensure unmatched potency, purity, and consistency.
此次擴張反映了Royal Biotek對大麻行業卓越、質量和誠信的堅定承諾。Surge Everglade 系列中的每款產品均採用最優質的原料和尖端的製造技術精心製成，以確保無與倫比的效力、純度和一致性。
"The addition of new products to the Everglade line is a pivotal moment for Royal Biotek, reinforcing our leadership in the fast-evolving cannabis and white label markets," Oswald added. "Our dedication to innovation, customer satisfaction, and regulatory compliance continues to set the standards of excellence in the industry."
奧斯瓦爾德補充說：“在Everglade系列中增加新產品對Royal Biotek來說是一個關鍵時刻，它鞏固了我們在快速發展的大麻和白標市場中的領導地位。”“我們對創新、客戶滿意度和監管合規性的奉獻精神繼續爲行業設定卓越標準。”
In addition to expanding the Everglade line, Royal Biotek is excited to announce an upcoming collaboration with a well-known celebrity tattoo artist. This partnership aims to create a new, all-natural tattoo aftercare product. This move is also expected to significantly increase media exposure. Further details will be shared upon finalizing the contracts.
除了擴大Everglade系列外，Royal Biotek還很高興地宣佈即將與一位知名的名人紋身師合作。此次合作旨在創造一種全新的全天然紋身後護理產品。預計此舉還將顯著增加媒體曝光度。更多細節將在合同敲定後分享。
Branded Legacy also announced the signing of three white label agreements with Surge Distribution Company and Kava & Hobbs just last quarter. These new deals increased revenue from quarter one by over $100,000.
就在上個季度，Branded Legacy還宣佈與Surge Distribution Company和Kava & Hobbs簽署了三份白標協議。這些新交易使第一季度的收入增加了超過100,000美元。
About Royal Biotek
關於皇家生物科技
Royal Biotek, a subsidiary of Branded Legacy, Inc., is at the forefront of developing innovative cannabis solutions. With a focus on quality and customer-centric products, Royal Biotek continues to lead the market in creating unique cannabis experiences for its diverse customer base.
Branded Legacy, Inc. 的子公司Royal Biotek處於開發創新大麻解決方案的最前沿。Royal Biotek專注於質量和以客戶爲中心的產品，繼續引領市場，爲其多元化的客戶群創造獨特的大麻體驗。
For more information about Royal Biotek and to explore their white label capabilities please visit:
如需了解有關 Royal Biotek 的更多信息並了解其白標功能，請訪問：
Original Copy of this Press Release:
本新聞稿的原件：
For media inquiries, please contact:
Investor Relations & Media Contact
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: [email protected]
Website:
媒體垂詢，請聯繫：
投資者關係與媒體聯繫人
Joe Holladay
品牌遺產
電話：321-345-3565
電子郵件：[電子郵件保護]
網站：
About Branded Legacy, Inc.:
關於品牌遺產, Inc.：
Branded Legacy, Inc. (OTC: BLEG) is a diversified holdings company focused on the biotech sector. With a commitment to excellence and innovation, Branded Legacy specializes in the development and marketing of cutting-edge products and services, including ventures in biotechnology, digital solutions, and wellness products.
Branded Legacy, Inc.（場外交易代碼：BLEG）是一家專注於生物技術領域的多元化控股公司。Branded Legacy致力於追求卓越和創新，專門從事尖端產品和服務的開發和營銷，包括生物技術、數字解決方案和健康產品領域的企業。
Safe Harbor Statement on Forward-Looking Language:
關於前瞻性語言的安全港聲明：
This release includes forward-looking statements, subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The company disclaims any intention or obligation to update or revise forward-looking statements. Forward-looking statements may be identified by words such as "may," "will," "expect," "believe," "anticipate," "estimate," and similar expressions.
本新聞稿包括前瞻性陳述，受風險和不確定性影響，這些風險和不確定性可能導致實際業績與當前預期存在重大差異。公司不表示有任何更新或修改前瞻性陳述的意圖或義務。前瞻性陳述可以用 “可能”、“將”、“期望”、“相信”、“預測”、“估計” 等詞語和類似表述來識別。
SOURCE Branded Legacy, Inc.
來源 Branded Legacy, Inc.
譯文內容由第三人軟體翻譯。